Answers are grounded in this paper and cite their sources.
Iron oxide nanoparticles (Fe₃O₄ NPs) have emerged as promising modulators of microbial metabolism, yet their biochemical effects on Bacillus strains with biocontrol potential remain poorly characterized. In this study we investigated the impact of Fe₃O₄ nanoparticles on the antioxidant response and antimicrobial activity of two Bacillus strains: B. subtilis CNMN-BB-10 and B. velezensis CNMN-BB-12. Both strains were cultivated in Mueller–Hinton and Luria–Bertani broths supplemented with Fe₃O₄ NPs at 5, 10 and 15 mg/L. Catalase specific activity, ABTS (2,2′-Azino-bis-(3-ethylbenzothiazoline-6-sulfonic acid)) radical scavenging capacity, protein content and inhibitory activity against four phytopathogenic bacteria and two Aspergillus species were assessed in cell-free supernatants and partially purified peptide fractions. The results of the study suggest that the combination of sub-inhibitory Fe₃O₄ NPs supplementation (10 mg/L) and appropriate culture medium represent a viable strategy to modulate and potentially enhance the bioactive compound profile of Bacillus strains.
No takes yet. Share an insight, caveat, or question.
Balan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: